Patients should always seek the advice of a doctor or pharmacist in case of adverse events.
If you wish to report an adverse event to ELC Group s.r.o., please find the contact information below:
To contact us about any other issue please call:
Pacienti by meli vždy požádat o radu svého lékare nebo lékárníka v prípade výskytu nežádoucích príhod.
Pokud chcete nahlásit nežádoucí príhodu spolecnosti ELC Group s r.o., prosím využijte kontaktních údaju níže:
Pro záležitosti, které se netýkaji farmakovigilance, kontaktujte prosím recepci:
+420 22 491 0000 nebo naše další pobočky.
Parvinder Punia and Pooja (Rai) Telavane – General Manager, Regulatory Affairs, of ELC Group’s new Mumbai office – will be representing ELC Group at the upcoming DIA EuroMeeting in Copenhagen (26 – 28 March 2012).
The EuroMeeting attracts more than 3,000 professionals from over 50 countries, bringing together professionals from the biopharmaceutical industry, contract service organisations, clinical research, regulatory agencies, health ministries, patients’ organisations and universities. This convergence affords attendees the opportunity to network with professional colleagues from around the world.
The ELC Group team will be meeting heads and senior staff from EU health agencies to discuss a range of policy issues, and will also be attending scheduled meeting with top executives from the pharmaceutical industry.
To book a meeting with Parvinder and Punia at the event, please email sales [at] elc-group [dot] com.
For futher information about the event, please visit: http://www.diahome.org/diahome/FlagshipMeetings/home.aspx?meetingid=25205
